NCT03887468View on ClinicalTrials.gov

Hemodialysis Adequacy Using a Heparin-grafted Dialyzer and a Citrate-enriched Dialysate

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

December 4, 2019

Study Completion Date

December 4, 2019

Conditions
Kidney DiseasesHemodialysis ComplicationEnd Stage Renal Disease
Interventions
DEVICE

EvoCit

hemodialysis using the combination of the Evodial dialyzer with a citrate enriched dialysate

DEVICE

EvoHep

hemodialysis using the combination of the Evodial dialyzer with a conventional bicarbonate based dialysate and systemic anticoagulation using unfractionated heparin

Trial Locations (2)

1020

CHU Brugmann, Laken

1090

UZ Brussel, Jette

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER

NCT03887468 - Hemodialysis Adequacy Using a Heparin-grafted Dialyzer and a Citrate-enriched Dialysate | Biotech Hunter | Biotech Hunter